BR8900697A - Proteina de antigeno circunsporozoitico;composicao de vacina;composicao utilizavel para o diagnostico de malaria em seres humanos;processo para a producao da proteina de antigeno circunsporozoitico;sistema de vetor baculovirus-celula de inseto - Google Patents

Proteina de antigeno circunsporozoitico;composicao de vacina;composicao utilizavel para o diagnostico de malaria em seres humanos;processo para a producao da proteina de antigeno circunsporozoitico;sistema de vetor baculovirus-celula de inseto

Info

Publication number
BR8900697A
BR8900697A BR898900697A BR8900697A BR8900697A BR 8900697 A BR8900697 A BR 8900697A BR 898900697 A BR898900697 A BR 898900697A BR 8900697 A BR8900697 A BR 8900697A BR 8900697 A BR8900697 A BR 8900697A
Authority
BR
Brazil
Prior art keywords
antigen protein
circumsporozoitic
circumsosozoitic
production
human beings
Prior art date
Application number
BR898900697A
Other languages
English (en)
Inventor
Mark A Cochran
Gale E Smith
Franklin Volvovitz
Original Assignee
Microgenesys Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Microgenesys Inc filed Critical Microgenesys Inc
Publication of BR8900697A publication Critical patent/BR8900697A/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86Viral vectors
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/44Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
    • C07K14/445Plasmodium
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011Details
    • C12N2710/14011Baculoviridae
    • C12N2710/14111Nucleopolyhedrovirus, e.g. autographa californica nucleopolyhedrovirus
    • C12N2710/14141Use of virus, viral particle or viral elements as a vector
    • C12N2710/14143Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
BR898900697A 1988-02-19 1989-02-17 Proteina de antigeno circunsporozoitico;composicao de vacina;composicao utilizavel para o diagnostico de malaria em seres humanos;processo para a producao da proteina de antigeno circunsporozoitico;sistema de vetor baculovirus-celula de inseto BR8900697A (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US15786488A 1988-02-19 1988-02-19

Publications (1)

Publication Number Publication Date
BR8900697A true BR8900697A (pt) 1989-10-17

Family

ID=22565606

Family Applications (1)

Application Number Title Priority Date Filing Date
BR898900697A BR8900697A (pt) 1988-02-19 1989-02-17 Proteina de antigeno circunsporozoitico;composicao de vacina;composicao utilizavel para o diagnostico de malaria em seres humanos;processo para a producao da proteina de antigeno circunsporozoitico;sistema de vetor baculovirus-celula de inseto

Country Status (7)

Country Link
EP (1) EP0329257A3 (pt)
JP (1) JPH025888A (pt)
KR (1) KR890013181A (pt)
AU (1) AU625713B2 (pt)
BR (1) BR8900697A (pt)
IL (1) IL89313A0 (pt)
ZA (1) ZA891169B (pt)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9002512D0 (en) * 1990-02-05 1990-04-04 3I Res Expl Ltd Polypeptides and dna encoding same
CA2037151A1 (en) * 1990-03-23 1991-09-24 F. Hoffmann-La Roche Ag Plasmodium sporozoite antigen
US6855316B1 (en) 1994-02-14 2005-02-15 University Of Hawaii Baculovirus produced Plasmodium falciparum vaccine
US6420523B1 (en) * 1992-04-13 2002-07-16 University Of Hawaii Baculovirus produced plasmodium falciparum vaccine
MXPA01008176A (es) 1999-02-18 2002-08-30 Rmf Dictagene Sa Vacuna contra el paludismo.
US7037681B2 (en) 2000-02-08 2006-05-02 University Of Hawaii Plasmodium falciparum merozoite surface protein-1 malaria produced in transgenic plants
US20030100106A1 (en) 2000-02-08 2003-05-29 Chang Sandra P. Baculovirus produced Plasmodium falciparum vaccine
AT501429B1 (de) * 2004-11-23 2007-05-15 Nessler Medizintechnik Gmbh Verfahren zur durchkontaktierung
JP4828312B2 (ja) * 2006-06-05 2011-11-30 日本圧着端子製造株式会社 防水コネクタ
US9169304B2 (en) 2012-05-01 2015-10-27 Pfenex Inc. Process for purifying recombinant Plasmodium falciparum circumsporozoite protein

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8404378D0 (en) * 1984-02-20 1984-03-28 Biogen Nv Dna sequence recombinant dna molecules
JPS63167797A (ja) * 1985-12-18 1988-07-11 マイクロジエネシス,インコ−ポレイテイド 選択された昆虫宿主細胞中で選択されたポリペプチドを製造する方法
EP0278941A1 (en) * 1987-01-30 1988-08-17 Smithkline Biologicals S.A. Expression of the P. falciparum circumsporozoite protein by yeast
IL85905A0 (en) * 1987-03-30 1988-09-30 Univ New York Immunogenic recombinant yeast expression product and method for purifying it

Also Published As

Publication number Publication date
EP0329257A2 (en) 1989-08-23
KR890013181A (ko) 1989-09-21
ZA891169B (en) 1989-11-29
IL89313A0 (en) 1989-09-10
EP0329257A3 (en) 1990-05-30
JPH025888A (ja) 1990-01-10
AU2992489A (en) 1989-08-24
AU625713B2 (en) 1992-07-16

Similar Documents

Publication Publication Date Title
PT100900A (pt) Processo para a preparacao de peptidos conjugados, e peptidos assim obtidos
NO922005D0 (no) Farmasoeytiske preparater
MX164971B (es) Procedimiento para la preparacion de conjugados de medicamentos citoxicos
KR900011476A (ko) 백신 제제
PT92487A (pt) Processo para a preparacao de derivados de peptidos
PT98944A (pt) Processo de preparacao de anticorpos alterados e de composicoes farmaceuticas para a prevencao e tratamento de infeccoes
PT88261A (pt) Processo para a preparacao de nucleosidos com efeito terapeutico
DK89090A (da) Farmaceutisk praeparat
DK489189D0 (da) Farmaceutisk praeparat
ATA293589A (de) Neue chinolinsulfonaminoderivate und verfahren zu deren herstellung sowie pharmazeutische zusammensetzung
DK705488A (da) Farmaceutisk praeparat
BR9206785A (pt) Bolsa para sangue e processo para sua produção
PT82651B (pt) Processo para a preparacao de vacinas sintenticas para a febre aftosa a base de peptideos
PT92213A (pt) Processo para a preparacao de conjugados de anticorpo-droga
BR9103036A (pt) Composto,formulacao farmaceutica e processo para a preparacao do composto
BR8900697A (pt) Proteina de antigeno circunsporozoitico;composicao de vacina;composicao utilizavel para o diagnostico de malaria em seres humanos;processo para a producao da proteina de antigeno circunsporozoitico;sistema de vetor baculovirus-celula de inseto
BR9206950A (pt) Composição farmacêutica e processo para sua preparação
PT89955A (pt) Processo para a preparacao de acidos 1-ciclopropil-quinolonocarboxilicos e seus derivados, e de n-ciclopropilanilinas utilizadas nesse processo
PT95656A (pt) Dispositivo de dupla extremidade para aplicacao e medicao de drogas
PT97550A (pt) Processo para a preparacao de uma composicao farmaceutica contendo ibuprofeno, e uma prostaglandina
DK603988D0 (da) Farmaceutisk praeparat
DK496889D0 (da) Peptidholdigt farmaceutisk praeparat
KR890700358A (ko) 인체 종양관련 항원
PT90524A (pt) Processo e dispositivo para o registo de artigos
BR8806332A (pt) Pigmentos monoazoicos,processo para sua preparacao e sua aplicacao

Legal Events

Date Code Title Description
FC Decision: refusal
B15K Others concerning applications: alteration of classification

Ipc: C12N 15/00 (2006.01), C12R 1/90 (2006.01), G01N 33

B15K Others concerning applications: alteration of classification

Ipc: C12N 15/86 (2006.01), C07K 14/445 (2006.0